Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer versus standard medical care after postpartum haemorrhage
2012-005782-12Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Apr 2013
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric derisomaltose in postpartum hemorrhage (PPH) (2 arms), sponsored by Pharmacosmos. Primary endpoint: Change in physical fatigue score from baseline to week 12. Started Apr 2013; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on 2012-005782-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005782-12.